F-18 fluoride positron emission tomography of the hip for osteonecrosis

被引:49
|
作者
Dasa, Vinod [3 ]
Adbel-Nabi, Hani [2 ]
Anders, Mark J. [3 ]
Mihalko, William M. [1 ]
机构
[1] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22908 USA
[2] Univ Buffalo, Dept Nucl Med, Buffalo, NY USA
[3] Univ Buffalo, Dept Orthopaed Surg, Buffalo, NY USA
关键词
D O I
10.1007/s11999-008-0219-2
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Osteonecrosis (ON) of the femoral head continues to be a devastating disorder for young patients. We evaluated the F-18 fluoride positron emission tomography (PET) imaging modality for use in detection of the bone involved in ON of the hip. We retrospectively reviewed the records of 60 consecutive patients diagnosed with ON and interviewed all by phone. Eleven patients (17 hips) of those interviewed agreed to participate in the study. We classified the ON using the University of Pennsylvania classification system and compared each patient's plain AP bone scan, single photon emission 3-D computed tomography, and MRI. ON was associated with HIV, alcohol, steroid use, and polycythemia vera in this group. Nine of 17 hips (8 patients) had acetabular increased uptake when using the F-18 fluoride PET scans that were not seen on MRI, single photon emission computed tomography, or bone scans. These data suggest earlier acetabular changes in osteonecrosis may exist that traditional imaging modalities do not reveal. Level of Evidence: Level III, diagnostic study. See the Guidelines for Authors for a complete description of levels of evidence.
引用
收藏
页码:1081 / 1086
页数:6
相关论文
共 50 条
  • [31] F-18 fluorodeoxyglucose positron emission tomography finding of Mazabraud syndrome
    Miyake, Mototaka
    Tateishi, Ukihide
    Maeda, Tetsuo
    Arai, Yasuaki
    Seki, Kunihiko
    Hasegawa, Tadashi
    Sugimura, Kazuro
    CLINICAL NUCLEAR MEDICINE, 2006, 31 (10) : 627 - 629
  • [32] PHARMACOKINETICS OF FLEROXACIN AS STUDIED BY POSITRON EMISSION TOMOGRAPHY AND [F-18] FLEROXACIN
    RUBIN, RH
    LIVNI, E
    BABICH, J
    ALPERT, NM
    LIU, YY
    THAM, E
    PROSSER, B
    CLEELAND, R
    CALLAHAN, RJ
    CORREIA, JA
    STRAUSS, HW
    FISCHMAN, AJ
    AMERICAN JOURNAL OF MEDICINE, 1993, 94 : 31 - 37
  • [33] POSITRON EMISSION TOMOGRAPHY OF F-18 LABELED LOWER FLUOROALKANES IN THE BRAIN
    HOLDEN, JE
    GATLEY, SJ
    POLCYN, RE
    JOURNAL OF NUCLEAR MEDICINE, 1981, 22 (06) : P90 - P90
  • [34] F-18 DEOXYGLUCOSE UPTAKE IN SARCOIDOSIS MEASURED WITH POSITRON EMISSION TOMOGRAPHY
    BRUDIN, LH
    VALIND, SO
    RHODES, CG
    PANTIN, CF
    SWEATMAN, M
    JONES, T
    HUGHES, JMB
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1994, 21 (04): : 297 - 305
  • [35] Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
    Shields, AF
    Grierson, JR
    Dohmen, BM
    Machulla, HJ
    Stayanoff, JC
    Lawhorn-Crews, JM
    Obradovich, JE
    Muzik, O
    Mangner, TJ
    NATURE MEDICINE, 1998, 4 (11) : 1334 - 1336
  • [36] A STUDY OF BROCAS APHASIA BY F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY
    METTER, EJ
    KEMPLER, D
    JACKSON, CA
    HANSON, WR
    MAZZIOTTA, JC
    PHELPS, ME
    ANNALS OF NEUROLOGY, 1987, 22 (01) : 134 - 134
  • [37] F-18 fluorodeoxyglucose positron emission tomography in an anorectal fistula with actinomycosis
    Hsu, CH
    Lee, CM
    Chia, CF
    Lin, YH
    CLINICAL NUCLEAR MEDICINE, 2004, 29 (07) : 452 - 453
  • [38] Positron emission tomography (PET) and [F-18]-fluorodeoxyglucose (FDG) in cancerology
    Maublant, J
    Vuillez, JP
    Talbot, JN
    Lumbroso, J
    Muratet, JP
    Herry, JY
    Artus, JC
    BULLETIN DU CANCER, 1998, 85 (11) : 935 - 950
  • [39] Postsurgical Atypical F-18 Fluorodeoxyglucose Positron Emission Tomography Uptake
    Dubroff, Jacob G.
    Alavi, Abass
    Friedberg, Joseph S.
    Cengel, Keith A.
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (11) : 808 - 810
  • [40] Melorheostosis bone scintigraphy and F-18 fluorodeoxyglucose positron emission tomography
    Kloos, RT
    Shreve, P
    Fig, L
    CLINICAL NUCLEAR MEDICINE, 1996, 21 (10) : 805 - 806